TOBRAMYCIN 80 MG/2 ML VIAL

What it is

TOBRAMYCIN 80 MG/2 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “tobramycin” and “tobramycin sulfate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “injection, solution” and “injection” and its route as intramuscular; intravenous.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hospira, Inc., Baxter Healthcare Corporation and Fresenius Kabi USA, LLC.

FDA’s Established Pharmacologic Class for it is Aminoglycoside Antibacterial.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $41.58 for 50 mL (50 × $0.83153 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 4 NDCs

• 00409-3578-01 · Hospira, Inc. · $0.83153 per ML · eff. 2026-09-23 filed
• 36000-0244-25 · Baxter Healthcare Corporation · $0.83153 per ML · eff. 2026-09-23 filed
• 63323-0306-02 · Fresenius Kabi USA, LLC · $0.83153 per ML · eff. 2026-09-23 filed
• 67457-0473-22 · Mylan Institutional LLC · $0.83153 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with TOBRAMYCIN 80 MG/2 ML VIAL.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.83153 per ML filed.

Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 14 have a higher middle NADAC price and 1 a lower one. The one in the middle is TOBRAMYCIN-DEXAMETH OPHTH SUSP, at $4.1784 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part B’s payment limit for HCPCS J3260, for 2026-10-01 to 2026-12-31, comes to $58.63 for 50 mL, or $1.1725 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.469 per 80 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 50 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 50 mL; your package may hold a different amount.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.